Skip to Main Content

Paper Details

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.
Mayo Clin Proc
75
2018

Datasets

Release 1.2